Jenny Berg

3.3k total citations · 1 hit paper
59 papers, 2.5k citations indexed

About

Jenny Berg is a scholar working on Pathology and Forensic Medicine, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jenny Berg has authored 59 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pathology and Forensic Medicine, 30 papers in Economics and Econometrics and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jenny Berg's work include Multiple Sclerosis Research Studies (31 papers), Health Systems, Economic Evaluations, Quality of Life (30 papers) and Systemic Sclerosis and Related Diseases (7 papers). Jenny Berg is often cited by papers focused on Multiple Sclerosis Research Studies (31 papers), Health Systems, Economic Evaluations, Quality of Life (30 papers) and Systemic Sclerosis and Related Diseases (7 papers). Jenny Berg collaborates with scholars based in Sweden, United Kingdom and France. Jenny Berg's co-authors include Gisela Kobelt, Peter Lindgren, Jennifer Eriksson, Mia Gannedahl, Alan J. Thompson, Daniela Capsa, Deborah Atherly, Olympia Hadjimichael, Uno Fors and Bengt Jönsson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Endodontics.

In The Last Decade

Jenny Berg

59 papers receiving 2.4k citations

Hit Papers

New insights into the burden and costs of multiple sclero... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenny Berg Sweden 29 1.6k 647 310 241 232 59 2.5k
Daniel Lubelski United States 37 2.3k 1.5× 90 0.1× 222 0.7× 267 1.1× 120 0.5× 254 4.2k
Rainer Koch Germany 30 224 0.1× 127 0.2× 620 2.0× 221 0.9× 212 0.9× 148 3.5k
Anne Keller Norway 30 1.1k 0.7× 138 0.2× 231 0.7× 51 0.2× 53 0.2× 54 2.9k
Brandon D. Lawrence United States 34 2.3k 1.5× 110 0.2× 100 0.3× 202 0.8× 311 1.3× 110 4.6k
D. Gladman Canada 19 278 0.2× 178 0.3× 117 0.4× 105 0.4× 1.4k 6.1× 37 2.7k
Carolyn L. Kerrigan Canada 35 363 0.2× 127 0.2× 103 0.3× 141 0.6× 54 0.2× 87 3.6k
James M. Schuster United States 31 775 0.5× 44 0.1× 612 2.0× 236 1.0× 115 0.5× 168 3.4k
Gisela Kobelt Sweden 42 2.8k 1.8× 1.4k 2.2× 577 1.9× 176 0.7× 2.0k 8.6× 116 5.7k
Robert Waller United States 25 386 0.2× 108 0.2× 298 1.0× 51 0.2× 97 0.4× 76 2.3k
Kristina Unnebrink Germany 29 400 0.3× 231 0.4× 76 0.2× 166 0.7× 810 3.5× 64 3.1k

Countries citing papers authored by Jenny Berg

Since Specialization
Citations

This map shows the geographic impact of Jenny Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Berg more than expected).

Fields of papers citing papers by Jenny Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Berg. The network helps show where Jenny Berg may publish in the future.

Co-authorship network of co-authors of Jenny Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Berg. A scholar is included among the top collaborators of Jenny Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Berg. Jenny Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Åström, Mimmi, et al.. (2023). Use of the visual analogue scale for health state valuation: a scoping review. Quality of Life Research. 32(10). 2719–2729. 41 indexed citations
2.
Lytsy, Per, Sven Engström, Mirjam Ekstedt, et al.. (2022). Outcomes associated with higher relational continuity in the treatment of persons with asthma or chronic obstructive pulmonary disease: A systematic review. EClinicalMedicine. 49. 101492–101492. 8 indexed citations
4.
Teni, Fitsum Sebsibe, Ola Rolfson, Jenny Berg, Reiner Leidl, & Kristina Burström. (2021). Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register. Journal of Clinical Medicine. 10(18). 4205–4205. 1 indexed citations
5.
Teni, Fitsum Sebsibe, Kristina Burström, Jenny Berg, Reiner Leidl, & Ola Rolfson. (2020). Predictive ability of the American Society of Anaesthesiologists physical status classification system on health-related quality of life of patients after total hip replacement: comparisons across eight EQ-5D-3L value sets. BMC Musculoskeletal Disorders. 21(1). 441–441. 12 indexed citations
6.
Berg, Jenny, Mia Gannedahl, Daniela Capsa, & Gisela Kobelt. (2016). Comparing Different Data on Disease Burden In Multiple Sclerosis. Value in Health. 19(7). A363–A363. 1 indexed citations
8.
Schweikert, Bernd, David Pittrow, Carmine Dario Vizza, et al.. (2014). Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries. BMC Health Services Research. 14(1). 246–246. 21 indexed citations
9.
Bexelius, Christin, Johan Lundberg, Xuan Wang, Jenny Berg, & Hans Hjelm. (2013). Annual Medical Costs of Swedish Patients with Type 2 Diabetes Before and After Insulin Initiation. Diabetes Therapy. 4(2). 363–374. 4 indexed citations
10.
Berg, Jenny, Luc Sauriol, Stuart J. Connolly, & Peter Lindgren. (2013). Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial. Canadian Journal of Cardiology. 29(10). 1249–1255. 3 indexed citations
11.
Berg, Jenny, et al.. (2010). Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. Quality of Life Research. 19(3). 381–390. 56 indexed citations
12.
Price, David, Jenny Berg, & Peter Lindgren. (2009). An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom. Allergy. 64(3). 431–438. 38 indexed citations
13.
Berg, Jenny & Peter Lindgren. (2007). Economic evaluation of FENO measurement in diagnosis and 1-year management of asthma in Germany. Respiratory Medicine. 102(2). 219–231. 29 indexed citations
14.
Kobelt, Gisela, Jenny Berg, & Peter Lindgren. (2006). Costs and quality of life in multiple sclerosis in The Netherlands. The European Journal of Health Economics. 7(S02). 55–64. 48 indexed citations
15.
Kobelt, Gisela, et al.. (2006). Costs and quality of life of multiple sclerosis in Switzerland. The European Journal of Health Economics. 7(S02). 86–95. 39 indexed citations
16.
Ekman, Mattias, Jenny Berg, Anders Wimo, Linus Jönsson, & Christopher R. McBurney. (2006). Health utilities in mild cognitive impairment and dementia: a population study in Sweden. International Journal of Geriatric Psychiatry. 22(7). 649–655. 22 indexed citations
17.
Kobelt, Gisela, et al.. (2006). Costs and quality of life of multiple sclerosis in Spain. The European Journal of Health Economics. 7(S02). 65–74. 151 indexed citations
18.
Kobelt, Gisela, Jenny Berg, Peter Lindgren, et al.. (2006). Costs and quality of life of multiple sclerosis in the United Kingdom. The European Journal of Health Economics. 7(S02). 96–104. 78 indexed citations
19.
Kobelt, Gisela, Jenny Berg, Peter Lindgren, & Bengt Jönsson. (2006). Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis. The European Journal of Health Economics. 7(S02). 5–13. 71 indexed citations
20.
Berg, Jenny. (2004). Economic evidence in trauma: a review. The European Journal of Health Economics. 5(S1). s84–s91. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026